V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310009437 | 310004516 | 1.73 | 66.5 | null | 2016-12-22 | 2016-12-28 | Cisplatin 7 day | N | N | 310017905 | CISPLATIN |
| 310009438 | 310004517 | null | 82.6 | Neo-adjuvant (N) | 2016-07-11 | 2016-07-17 | ALL UKALL2011 Maintenance A3 | null | N | 310017909 | BEXAROTENE |
| 310009439 | 310004520 | null | 53.4 | Palliative (P) | 2014-02-12 | 2014-02-12 | Ipilimumab | 2 | N | 310017926 | IPILIMUMAB |
| 310009440 | 310004522 | 1.72 | null | Neo-adjuvant (N) | 2014-07-23 | 2014-07-26 | BEVACIZUMAB + CARBO + PACLITAXEL | 02 | N | 310017935 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 310009441 | 310004524 | null | 61.4 | Palliative (P) | 2017-08-17 | 2017-10-26 | ALL UKALL2011 Maintenance C1 | 02 | N | 310017972 | CARBOPLATIN + ETOPOSIDE |
| 310009442 | 310010692 | 1.6 | 64.5 | Curative (C) | 2017-05-22 | 2017-05-28 | Cisplatin 7 day | 02 | N | 310017977 | CISPLATIN |
| 310009443 | 310004527 | 0 | null | Neo-adjuvant (N) | null | 2015-04-29 | Bexarotene | N | null | 310017980 | BEXAROTENE |
| 310009444 | 310004528 | 1.5 | 77 | Palliative (P) | null | 2019-03-06 | Cisplatin 7 day | N | null | 310017984 | CISPLATIN |
| 310009445 | 310004530 | null | 80.3 | Palliative (P) | 2015-04-20 | 2015-05-16 | Rituximab | 2 | null | 310018005 | RITUXIMAB |
| 310009446 | 310009730 | 1.66 | null | Disease modification (D) | 2016-02-08 | 2016-03-12 | GDP | N | N | 310018013 | GDP |
| 310009447 | 310004533 | 1.82 | 61 | Palliative (P) | 2016-03-30 | 2016-11-19 | Bexarotene | N | N | 310018019 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 310009448 | 310004536 | 1.72 | 101 | Palliative (P) | 2018-02-08 | 2018-02-08 | Bevacizumab + CARBOPLATIN + PACLITAXEL | N | N | 310018037 | ESHAP |
| 310009449 | 310007924 | 1.77 | null | Palliative (P) | 2018-04-09 | 2018-04-24 | Ipilimumab | N | null | 310018046 | IPILIMUMAB |
| 310009450 | 310004546 | null | 76.1 | Curative (C) | null | 2016-05-29 | Cyclophosphamide High Dose | null | null | 310018070 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 310009451 | 310004548 | null | 92.2 | Disease modification (D) | 2018-02-02 | 2018-02-08 | Rituximab | 02 | N | 310018083 | RITUXIMAB |
| 310009453 | 310004551 | 1.8 | 57.5 | Palliative (P) | 2017-09-23 | 2017-10-22 | Docetaxel 75mg/m2 (21 day) | 02 | N | 310018091 | DOCETAXEL |
| 310009454 | 310004554 | 1.49 | 61 | Neo-adjuvant (N) | 2017-10-29 | 2017-11-29 | Docetaxel 75mg/m2 (21 day) | 2 | N | 310018107 | DOCETAXEL |
| 310009455 | 310004555 | 1.62 | 56.2 | Adjuvant (A) | 2015-12-24 | 2016-02-15 | CARBOPLATIN + ETOPOSIDE | N | N | 310018110 | UKALL2011 |
| 310009456 | 310004557 | 1.78 | 65.7 | Curative (C) | 2015-04-20 | 2015-04-23 | Methotrexate intrathecal | 02 | null | 310018115 | METHOTREXATE INTRATHECAL |
| 310009457 | 310004558 | 1.72 | 70.4 | Disease modification (D) | 2016-07-23 | 2016-07-25 | Methotrexate intrathecal | N | N | 310018121 | METHOTREXATE INTRATHECAL |
| 310009458 | 310004561 | 1.6 | 69 | Palliative (P) | 2017-12-21 | 2017-12-21 | Rituximab | Y | N | 310018125 | RITUXIMAB |
| 310009459 | 310004562 | 1.85 | 76 | Palliative (P) | null | 2017-03-03 | ESHAP | N | N | 310018127 | CARBOPLATIN + ETOPOSIDE |
| 310009460 | 310007936 | 1.65 | 83.3 | Palliative (P) | 2018-02-26 | 2018-09-29 | Docetaxel | N | N | 310018132 | DOCETAXEL |
| 310009461 | 310007936 | 1.76 | 99.7 | Palliative (P) | 2018-09-03 | 2018-09-07 | Ipilimumab | 2 | N | 310018132 | IPILIMUMAB |
| 310009462 | 310004570 | 1.69 | null | Curative (C) | null | 2014-07-26 | Cyclophosphamide High Dose | 2 | N | 310018158 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 310009465 | 310004575 | 1.59 | 60.6 | Palliative (P) | 2017-08-26 | 2017-12-01 | ETOPOSIDE | N | N | 310018191 | ETOPOSIDE |
| 310009466 | 310004581 | null | 60.6 | Curative (C) | null | 2018-05-22 | Rituximab | 02 | N | 310018236 | RITUXIMAB |
| 310009467 | 310010699 | null | null | Curative (C) | 2018-08-04 | 2018-08-06 | Cisplatin 7 day | N | N | 310018245 | CISPLATIN |
| 310009468 | 310004584 | 1.63 | 67 | Curative (C) | 2016-08-24 | 2016-08-31 | CHOP R - 21 days | N | N | 310018259 | CHOP R |
| 310009469 | 310004586 | 1.43 | null | Palliative (P) | null | 2016-04-19 | Docetaxel+Gemcitabine (no prior RT) | N | N | 310018276 | CYCLOPHOSPHAMIDE + ETOPOSIDE + PROCARBAZINE |
| 310009470 | 310007947 | 1.63 | 52.2 | Curative (C) | 2015-02-01 | 2015-02-01 | Cyclophosphamide High Dose | N | null | 310018278 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 310009471 | 310007949 | null | 106 | Palliative (P) | 2016-02-10 | 2016-02-11 | Bexarotene | 2 | N | 310018282 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 310009473 | 310004594 | 1.66 | 11.9 | Curative (C) | 2018-01-26 | 2018-01-28 | GDP | Y | N | 310018298 | GDP |
| 310009474 | 310004597 | 1.65 | 57.9 | Curative (C) | 2015-08-21 | 2015-08-22 | Cisplatin 100 + RT(H&N) 1 day | null | null | 310018316 | CISPLATIN + RT |
| 310009475 | 310004599 | 1.72 | 74 | Disease modification (D) | 2012-11-23 | 2014-06-18 | Docetaxel + Gemcitabine with GCSF | N | N | 310018317 | DOCETAXEL + GEMCITABINE |
| 310009476 | 310004604 | 1.49 | 77 | null | 2013-10-26 | 2013-11-05 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | N | 310018337 | CARBOPLATIN + ETOPOSIDE |
| 310009477 | 310007956 | 1.8 | 29.7 | null | 2016-10-13 | 2016-10-21 | ALL UKALL2011 Del Int A Pt1 (PAsp) | N | N | 310018342 | CARBOPLATIN + ETOPOSIDE |
| 310009478 | 310004608 | 1.88 | 61 | Palliative (P) | 2019-02-21 | 2019-03-05 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | N | 310018356 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 310009479 | 310007958 | 1.88 | 100.4 | Palliative (P) | 2017-03-04 | 2017-03-05 | Methotrexate intrathecal | N | N | 310018360 | METHOTREXATE INTRATHECAL |
| 310009480 | 310004611 | null | 95.6 | Palliative (P) | 2017-02-25 | 2017-02-27 | Bexarotene | N | N | 310018361 | ESHAP |
| 310009483 | 310004615 | null | 47.3 | Curative (C) | 2017-03-22 | 2017-03-23 | BEVACIZUMAB + CARBO + PACLITAXEL | 02 | null | 310018370 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 310009484 | 310007961 | 1.62 | 56.4 | Neo-adjuvant (N) | null | 2013-07-31 | Carboplatin + Etoposide iv&po | N | N | 310018386 | CARBOPLATIN + ETOPOSIDE |
| 310009485 | 310004619 | 1.9 | 32.8 | Curative (C) | 2017-06-01 | 2017-06-03 | Cisplatin 100 + RT(H&N) 1 day | N | N | 310018389 | CISPLATIN + RT |
| 310009486 | 310004620 | 1.64 | 56 | Curative (C) | 2016-01-18 | 2016-01-18 | Bexarotene | N | N | 310018418 | UKALL2011 |
| 310009487 | 310004621 | 1.65 | 116.2 | Palliative (P) | 2016-04-02 | 2016-05-31 | ETOPOSIDE | Y | N | 310018440 | ETOPOSIDE |
| 310009488 | 310009750 | 1.56 | 56.2 | Palliative (P) | 2017-09-07 | 2017-09-15 | Ipilimumab | N | N | 310018444 | IPILIMUMAB |
| 310009489 | 310007965 | 1.79 | 80.1 | Palliative (P) | 2018-01-09 | 2018-01-10 | Docetaxel + Gemcitabine (prior RT) | N | N | 310018446 | DOCETAXEL + GEMCITABINE |
| 310009490 | 310004628 | 1.65 | 84.6 | Palliative (P) | null | 2014-10-31 | Bexarotene | N | N | 310018458 | CARBOPLATIN + ETOPOSIDE |
| 310009491 | 310004630 | 1.71 | 93.6 | Palliative (P) | 2015-04-27 | 2015-05-04 | Etoposide oral | 2 | N | 310018464 | ETOPOSIDE |
| 310009492 | 310007969 | 1.57 | 80.6 | Palliative (P) | 2014-01-30 | 2014-01-31 | CHOP R - 21 days | 02 | N | 310018464 | CHOP R |